Close Menu
Chicago News Journal
    Facebook X (Twitter) Instagram
    • Contact us
    • About us
    • Amazon Disclaimer
    • DMCA / Copyrights Disclaimer
    • Privacy Policy
    • Terms and Conditions
    Facebook X (Twitter) Instagram YouTube TikTok
    Chicago News JournalChicago News Journal
    • Home
    • US News
    • Politics
    • Business
    • Science
    • Technology
    • LifeStyle
    • Music
    • Television
    • Film
    • Books
    • Contact
      • About us
      • Amazon Disclaimer
      • DMCA / Copyrights Disclaimer
      • Privacy Policy
      • Terms and Conditions
    Chicago News Journal
    Home»Science

    Ozempic and Wegovy could help people quit smoking

    By July 30, 2024 Science
    Facebook Twitter Pinterest LinkedIn Tumblr Email Reddit Telegram
    Ozempic and Wegovy could help people quit smoking

    Ozempic and Wegovy could help people quit smoking

    Ozempic could treat many more conditions than just type 2 diabetes and obesity

    myskin/Shutterstock

    Another study adds credence to the idea that semaglutide – the drug in medications such as Ozempic and Wegovy – could help treat addiction. Researchers found that people who were prescribed the drug for type 2 diabetes were then less likely to seek medical care for tobacco use than those taking other diabetes medications. 

    Semaglutide helps treat obesity and type 2 diabetes by mimicking a hormone that reduces appetite and regulates blood sugar levels. Previous research has also linked it to lower rates of cannabis use disorder and alcoholism. 

    To learn about semaglutide’s effect on tobacco addiction, Rong Xu at Case Western Reserve University in Ohio and her colleagues collected data from electronic health records on nearly 223,000 people in the US with type 2 diabetes and tobacco addiction. Nearly 6000 of them had been prescribed semaglutide, while the rest used one of seven other diabetes medications.

    The researchers then tracked whether the individuals met with a healthcare provider for any tobacco use or received smoking cessation medications or counselling within a year of starting the medications.  

    After accounting for variables such as age, sex, race and certain health conditions, the team found that those using semaglutide were less likely to receive any form of tobacco-related healthcare, on average, than those taking other medications. The researchers took this as a probable indication that these individuals had been more successful at quitting smoking.

    For instance, semaglutide users were 32 per cent less likely to receive this care than insulin users and 18 per cent less likely than metformin users.  

    It could be that people who take semaglutide are less likely to seek medical care for their tobacco use without having necessarily abstained from such products. But Xu says that all the individuals sought tobacco-related healthcare at similar rates before starting their type 2 diabetes medications, so semaglutide may actually have been helpful. 

    This study wasn’t a randomised-controlled trial, which is the best form of medical evidence, and so these findings don’t definitively show that semaglutide is behind the effect, says Patricia Grigson-Kennedy at Pennsylvania State University. Still, other research shows semaglutide reduces activity in brain regions involved with reward processing and cravings, so it is possible that there could be some causal connection.

    Topics:

    Read the original article here

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email Reddit Telegram

    You might also be interested in...

    ZWO Seestar S30 Plus review

    November 10, 2026

    'The first species we might be able to communicate with, interact with vocally, might be a bird': An animal researcher explains how she decoded birdsong

    November 10, 2026

    Highly active Russian volcano plays peek-a-boo with an astronaut

    November 10, 2026

    Iran war helps fuel global drop in fossil fuel emissions — but theres a catch

    November 10, 2026

    Nazca infant had rare, fatal birth defect that left her with one central eye 1,600 years ago

    November 9, 2026

    Did human sacrifice help lower violence? New research in Peru leaves intriguing question

    November 9, 2026
    Popular Posts

    Interview with Aletheia von Gottlieb, Author of Love Off the Ice (Sweet Snowfall Kisses Book 1) – NewInBooks

    What Were Wearing: Friendsgiving

    In historic move, House Democrats nominate Hakeem Jeffries for speaker of the House

    Book Riots Deals of the Day for November 18, 2026

    Voyager 1 at one light-day: Historian revisits Golden Record's forgotten details

    DWTS Fans Discover Sneaky Loophole To Rig Votes For Favorite

    Categories
    • Books (2,456)
    • Business (3,449)
    • Events (34)
    • Film (1,062)
    • LifeStyle (2,922)
    • Music (2,796)
    • Politics (2,355)
    • Science (1,951)
    • Technology (1,817)
    • Television (3,628)
    • US News (3,293)
    Archives
    Useful Links
    • Contact us
    • About us
    • Amazon Disclaimer
    • DMCA / Copyrights Disclaimer
    • Privacy Policy
    • Terms and Conditions
    Popular Posts
    • International tourists to U.S. fall, but Americans keep going abroadInternational tourists to U.S. fall, but Americans keep going abroad
    • India’s IDFC First Bank says merger will boost credit growth
    • Paramount-Warner Bros. movie slate needs animation to rival Disney, UniversalParamount-Warner Bros. movie slate needs animation to rival Disney, Universal
    • Carrie Fisher Lives Through Joy With Kids, Bryan LourdCarrie Fisher Lives Through Joy With Kids, Bryan Lourd
    • Starbucks Workers United union strikes on Red Cup DayStarbucks Workers United union strikes on Red Cup Day
    Archives
    Categories
    • Books
    • Business
    • Events
    • Film
    • LifeStyle
    • Music
    • Politics
    • Science
    • Technology
    • Television
    • US News
    Facebook X (Twitter) Instagram YouTube TikTok
    © 2026 Chicago News Journal. All rights reserved. All articles, images, product names, logos, and brands are property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Terms of Use and Privacy Policy.

    Type above and press Enter to search. Press Esc to cancel.